1. Home
  2. ALEX vs NTLA Comparison

ALEX vs NTLA Comparison

Compare ALEX & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alexander & Baldwin Inc. REIT Holding Company

ALEX

Alexander & Baldwin Inc. REIT Holding Company

HOLD

Current Price

$20.78

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$11.84

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALEX
NTLA
Founded
1870
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
ALEX
NTLA
Price
$20.78
$11.84
Analyst Decision
Hold
Buy
Analyst Count
3
18
Target Price
$21.00
$18.34
AVG Volume (30 Days)
671.0K
5.9M
Earning Date
02-27-2026
02-26-2026
Dividend Yield
6.74%
N/A
EPS Growth
65.09
N/A
EPS
1.01
N/A
Revenue
$226,062,000.00
$57,528,000.00
Revenue This Year
N/A
$1.71
Revenue Next Year
$2.12
N/A
P/E Ratio
$20.53
N/A
Revenue Growth
N/A
33.52
52 Week Low
$15.07
$5.90
52 Week High
$21.03
$28.25

Technical Indicators

Market Signals
Indicator
ALEX
NTLA
Relative Strength Index (RSI) 66.97 47.64
Support Level $20.73 $11.21
Resistance Level $20.77 $12.54
Average True Range (ATR) 0.04 1.09
MACD -0.06 -0.29
Stochastic Oscillator 72.73 15.19

Price Performance

Historical Comparison
ALEX
NTLA

About ALEX Alexander & Baldwin Inc. REIT Holding Company

Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: